Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

External Validation of the ELAN-HF Score, Predicting 6-Month All-Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure.

Salah K, Stienen S, Moons AHM, Bakx ALM, van Pol PE, Kortz RAM, Ferreira JP, Marques I, Schroeder-Tanka JM, Keijer JT, Bayes-Genis A, Pinto YM, Tijssen JG, Kok WE.

J Am Heart Assoc. 2019 Jul 16;8(14):e010309. doi: 10.1161/JAHA.118.010309. Epub 2019 Jul 12.

2.

Correction to: Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia.

Bolhuis K, Bakker LJ, Keijer JT, de Vries PJ.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2223. doi: 10.1007/s10096-018-3355-y.

3.

Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia.

Bolhuis K, Bakker LJ, Keijer JT, de Vries PJ.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1553-1562. doi: 10.1007/s10096-018-3284-9. Epub 2018 May 31. Erratum in: Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2223.

4.

NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).

Stienen S, Salah K, Moons AH, Bakx AL, van Pol P, Kortz RAM, Ferreira JP, Marques I, Schroeder-Tanka JM, Keijer JT, BayƩs-Genis A, Tijssen JGP, Pinto YM, Kok WE.

Circulation. 2018 Apr 17;137(16):1671-1683. doi: 10.1161/CIRCULATIONAHA.117.029882. Epub 2017 Dec 14.

PMID:
29242350
5.

A man with cardiac Lyme borreliosis.

van Hattem JM, Keijer JT, Nijveldt R.

CMAJ. 2015 Oct 6;187(14):1071-1073. doi: 10.1503/cmaj.141468. Epub 2015 Jul 6. No abstract available.

6.

Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes.

Stienen S, Salah K, Moons AH, Bakx AL, van Pol PE, Schroeder-Tanka JM, Voogel AJ, Keijer JT, Kortz RA, Dickhoff C, Meregalli PG, Tijssen JG, Pinto YM, Kok WE.

Am Heart J. 2014 Jul;168(1):30-6. doi: 10.1016/j.ahj.2014.04.008. Epub 2014 Apr 23.

PMID:
24952857
7.

Influence of left bundle branch block on left ventricular volumes, ejection fraction and regional wall motion.

Brunekreeft JA, Graauw M, de Milliano PA, Keijer JT.

Neth Heart J. 2007;15(3):89-94.

8.

Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: implications for transmural assessment of myocardial perfusion.

Keijer JT, van Rossum AC, Wilke N, van Eenige MJ, Jerosch-Herold M, Bronzwaer JG, Visser CA.

J Cardiovasc Magn Reson. 2000;2(3):189-200.

PMID:
11545116
9.

Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: quantitative comparison with (201)Thallium-SPECT and coronary angiography.

Keijer JT, van Rossum AC, van Eenige MJ, Bax JJ, Visser FC, Teule JJ, Visser CA.

J Magn Reson Imaging. 2000 Jun;11(6):607-15.

PMID:
10862059
10.

Myocardial perfusion imaging: clinical experience and recent progress in radionuclide scintigraphy and magnetic resonance imaging.

Keijer JT, Bax JJ, van Rossum AC, Visser FC, Visser CA.

Int J Card Imaging. 1997 Oct;13(5):415-31. Review.

PMID:
9360178
11.

Semiquantitation of regional myocardial blood flow in normal human subjects by first-pass magnetic resonance imaging.

Keijer JT, van Rossum AC, van Eenige MJ, Karreman AJ, Hofman MB, Valk J, Visser CA.

Am Heart J. 1995 Oct;130(4):893-901.

PMID:
7572601

Supplemental Content

Loading ...
Support Center